These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8147303)

  • 1. Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy.
    Cannon RO; Tripodi D; Dilsizian V; Panza JA; Fananapazir L
    Am J Cardiol; 1994 Mar; 73(8):571-6. PubMed ID: 8147303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
    Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ
    J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L; Cannon RO; Tripodi D; Panza JA
    Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
    Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of DDD pacing on ergospirometric parameters and neurohormonal activity in patients with hypertrophic obstructive cardiomyopathy.
    Simantirakis EN; Kanoupakis EM; Kochiadakis GE; Kanakaraki MK; Parthenakis FI; Manios EG; Markianos E; Vardas PE
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2269-72. PubMed ID: 9825331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute and chronic effects of DDD pacing on left ventricular diastolic function in patients with non-obstructive hypertrophic cardiomyopathy.
    Watanabe K; Sekiya M; Ikeda S; Funada J; Suzuki J; Sueda S; Tsuruoka T
    Jpn Circ J; 2001 Apr; 65(4):283-8. PubMed ID: 11316124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
    Maron BJ; Nishimura RA; McKenna WJ; Rakowski H; Josephson ME; Kieval RS
    Circulation; 1999 Jun; 99(22):2927-33. PubMed ID: 10359738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points.
    Ommen SR; Nishimura RA; Squires RW; Schaff HV; Danielson GK; Tajik AJ
    J Am Coll Cardiol; 1999 Jul; 34(1):191-6. PubMed ID: 10400010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual-chamber DDD pacing in NYHA III-IV functional class dilated cardiomyopathy: short and middle-term evaluation].
    Occhetta E; Bortnik M; Francalacci G; Sarasso G; Piccinino C; Pistono M; Marenna B; Paffoni P; Sacchetti M; Inglese E; Trevi G
    Cardiologia; 1998 Dec; 43(12):1327-35. PubMed ID: 9988941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
    Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
    Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy.
    McAreavey D; Fananapazir L
    Am J Cardiol; 1992 Sep; 70(6):651-6. PubMed ID: 1510015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy].
    Takahashi M; Horinaka S; Takada M; Matsumoto N; Tsuchiya N; Yabe A; Onoda M; Murate J; Masuda T; Ishikawa K; Takeda K; Matsuoka H
    J Cardiol; 1997 Jun; 29(6):345-52. PubMed ID: 9211094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000.
    Erwin JP; Nishimura RA; Lloyd MA; Tajik AJ
    Mayo Clin Proc; 2000 Feb; 75(2):173-80. PubMed ID: 10683657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy.
    Rishi F; Hulse JE; Auld DO; McRae G; Kaltman J; Kanter K; Williams W; Campbell RM
    J Am Coll Cardiol; 1997 Mar; 29(4):734-40. PubMed ID: 9091517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
    Park MH; Gilligan DM; Bernardo NL; Topaz O
    Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy.
    Honda T; Shono H; Koyama J; Tsuchiya T; Hayashi M; Hirayama T; Uesugi H; Honda T
    Circ J; 2005 May; 69(5):536-42. PubMed ID: 15849439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers.
    Rediker DE; Eagle KA; Homma S; Gillam LD; Harthorne JW
    Am J Cardiol; 1988 Feb; 61(4):323-9. PubMed ID: 3341209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The long-term effects of dual-chamber stimulation in 8 patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy].
    Capezzuto A; Guerra R; Pontillo D; Sassara M; Savelli MS; Castellani R; Scabbia EV
    Ital Heart J Suppl; 2000 Feb; 1(2):250-5. PubMed ID: 10731383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of hypertrophic obstructive cardiomyopathy refractory to medical treatment by DDD pacing].
    Tascón J; Albarrán A; Pérez-Carasa MA; Andreu J; Rodríguez J; Coma R; Cosío FG
    Rev Esp Cardiol; 1994 May; 47(5):294-302. PubMed ID: 8016438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.